SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.810.0%3:58 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (7859)11/28/1998 6:51:00 PM
From: wolfdog2  Read Replies (1) of 17367
 
Bluegreen, this may have been answered by someone one else, but the taxes they will avoid are from revenues generated outside the U.S. On revenues earned here, Uncle Sam will still get his cut.

Also what could the FDA care about whether XOMA pays more or less taxes? Taxation is totally outside their realm of operations.
By your reasoning foreign companies would have a tougher time getting FDA approval than domestic ones. And that as you must realize just ain't the case.

One problem that I have with the move is that for some perverse reason companies domiciled offshore tend to get lower p/e's than onshore companies. So some of what we save on tax may be lost in market capitalization.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News